GLSI — Greenwich Lifesciences Share News
0.000.00%
- $235.29m
- $226.42m
Greenwich Lifesciences Inc reports results for the quarter ended June 30 - Earnings Summary
Greenwich Lifesciences Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Greenwich Lifesciences Announces Approval To Expand FLAMINGO-01 Into The United Kingdom
U.S. STOCKS ON THE MOVE-Yum Brands, AMD, Nuvation Bio
U.S. STOCKS ON THE MOVE-Yum Brands, AMD, Nuvation Bio
U.S. STOCKS ON THE MOVE-Domino's, LXP Industrial, Yum Brands
Greenwich LifeSciences rises as regulators allow expansion of late-stage breast cancer study
Brief: Greenwich Lifesciences Provides Clinical Updates On FLAMINGO-01
U.S. STOCKS ON THE MOVE-Natera, nLIGHT, Micron
U.S. STOCKS ON THE MOVE-Natera, nLIGHT, Forte Biosciences
U.S. STOCKS ON THE MOVE-Levi's, Meta, PepsiCo
U.S. STOCKS ON THE MOVE-Levi, Ionis Pharmaceuticals, Gloo Holdings
Greenwich LifeSciences rises after EMA update for breast cancer drug
Brief: Greenwich Lifesciences Provides Update Regarding Form 10-K Filing
Advisory: Alerts incorrectly tagged to Greenwich Lifesciences withdrawn
U.S. STOCKS ON THE MOVE-Adobe, Biogen, Sable
U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO
U.S. STOCKS ON THE MOVE-TopBuild, MDA Space, Biogen
Greenwich LifeSciences rises on breast cancer vaccine immune data